Clinical trial
Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III…
NCT00243113 · Aichi Cancer Center, Other · Completed
Key facts
| NCT number | NCT00243113 |
|---|---|
| Title | Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx |
| Official title | Multi-Institutional Phase II Study of Weekly Docetaxel and Concurrent Radiotherapy for Laryngeal and Hypopharyngeal Cancer in the Group of Elderly and/or Patients With Medical Illness |
| Lead sponsor | Aichi Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Radiation |
| Interventions | docetaxel, radiation therapy |
| Enrollment | 50 |
| Start date | Jun 1, 2004 |
| Primary completion | Mar 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Oct 21, 2005 |
| Last update posted | Mar 26, 2013 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: